Even if IMU says the data so far are compelling, big pharma's hesitation tells holders anther story which is - not good enough to get involved.
I think the above statement is true .... as much as some on here won't like it, we need third party validation by a big pharma corporation of the 'compelling' results we are constantly told about by the 3 amigos (LC, PH and YF) .... until then expect more of the same - CR's, depressed share prices and the constant touting of how 'compelling' the results are that they are "seeing" knowing that IMU are just not prepared to release them in any greater detail via an ASX announcement to date than what they have ? Is that a positive or negative ... who knows but I guess we will find out during 2025 ?
A big pharma license deal for one indication combined with funding for advanced trials like a registrational trial would certainly change market sentiment and IMHO a 1:10 share consolidation also wouldn't go astray either
Glad they did the Webinar and faced the shareholders but I wasn't expecting much more than we got and so I have come away feeling the same as what I did last week and the week before ... IMO we will know in the next 6-12 months whether IMU has a future or not ?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)